Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease worldwide, being non-alcoholic steatohepatitis (NASH) its most clinically relevant form. Given the risks associated with taking a liver biopsy, the design of accurate non-invasive methods to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Marañón, Patricia, Fernández-García, Carlos Ernesto, Isaza, Stephania C., Rey, Esther, Gallego-Durán, Rocío, Montero-Vallejo, Rocío, de Cía, Javier Rodríguez, Ampuero, Javier, Romero-Gómez, Manuel, García-Monzón, Carmelo, González-Rodríguez, Águeda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131682/
https://www.ncbi.nlm.nih.gov/pubmed/35614516
http://dx.doi.org/10.1186/s40364-022-00383-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131682/
https://www.ncbi.nlm.nih.gov/pubmed/35614516
http://dx.doi.org/10.1186/s40364-022-00383-3

Ejemplares similares